Geffon 250 Tablet 10 is used to treat selected adults with non-small-cell lung cancer that has specific epidermal growth factor receptor (EGFR) mutations. It is a single-ingredient anticancer medicine containing gefitinib, an EGFR tyrosine kinase inhibitor.
Gefitinib blocks abnormal EGFR signalling that promotes cancer-cell growth and survival. Treatment should be started and monitored by an oncology specialist after appropriate tumour testing.
Before starting, tell your doctor about lung, liver or eye problems and all other medicines you take. Report new or worsening breathlessness, persistent diarrhoea, severe skin reactions or eye pain promptly.



































